SAREPTA THERAPEUTICS, INC. Increase (Decrease) in Accounts Receivable and Other Operating Assets
SAREPTA THERAPEUTICS, INC. (SRPT) reported Increase (Decrease) in Accounts Receivable and Other Operating Assets of $20.96 million for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets · last filed 2014-08-07
- SAREPTA THERAPEUTICS, INC. increase (decrease) in accounts receivable and other operating assets for the quarter ending 2014-06-30 was $10.62M.
- SAREPTA THERAPEUTICS, INC. increase (decrease) in accounts receivable and other operating assets for the quarter ending 2014-03-31 was $10.34M, a 777.50% increase year-over-year.
- SAREPTA THERAPEUTICS, INC. increase (decrease) in accounts receivable and other operating assets for the quarter ending 2013-12-31 was -$3.32M, a 236.95% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. increase (decrease) in accounts receivable and other operating assets for the quarter ending 2013-09-30 was $1.07M.
- SAREPTA THERAPEUTICS, INC. increase (decrease) in accounts receivable and other operating assets for fiscal 2013 was -$2.80M, a 178.09% decline from fiscal 2012.
- SAREPTA THERAPEUTICS, INC. increase (decrease) in accounts receivable and other operating assets for fiscal 2012 was $3.59M, a 237.44% increase from fiscal 2011.
- SAREPTA THERAPEUTICS, INC. increase (decrease) in accounts receivable and other operating assets for fiscal 2011 was $1.06M.
| Period end | Increase (Decrease) in Accounts Receivable and Other Operating Assets 3 month | Increase (Decrease) in Accounts Receivable and Other Operating Assets 6 month | Increase (Decrease) in Accounts Receivable and Other Operating Assets 9 month | Increase (Decrease) in Accounts Receivable and Other Operating Assets 12 month | Increase (Decrease) in Accounts Receivable and Other Operating Assets 395 month | Increase (Decrease) in Accounts Receivable and Other Operating Assets 398 month | Increase (Decrease) in Accounts Receivable and Other Operating Assets 401 month | Increase (Decrease) in Accounts Receivable and Other Operating Assets 404 month |
|---|---|---|---|---|---|---|---|---|
| 2014-06-30 | $10.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $20.96M 10-Q · filed 2014-08-07 | $17.64M derived: sum of 3 quarters · filed 2014-08-07 | $18.70M derived: sum of 4 quarters · filed 2014-08-07 | ||||
| 2014-03-31 | $10.34M 10-Q · filed 2014-05-08 | $7.02M derived: sum of 2 quarters · filed 2014-05-08 | $8.09M derived: sum of 3 quarters · filed 2014-05-08 | $6.36M derived: sum of 4 quarters · filed 2014-08-07 | $16.30M 10-Q · filed 2014-05-08 | |||
| 2013-12-31 | -$3.32M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$2.25M derived: sum of 2 quarters · filed 2014-03-03 | -$3.98M derived: sum of 3 quarters · filed 2014-08-07 | -$2.80M 10-K · filed 2014-03-03 | $5.96M 10-K · filed 2014-03-03 | |||
| 2013-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$658.00K derived: sum of 2 quarters · filed 2014-08-07 | $520.00K 10-Q · filed 2013-11-12 | $2.94M derived: sum of 4 quarters · filed 2014-08-07 | $9.28M 10-Q · filed 2013-11-12 | |||
| 2013-06-30 | -$1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$549.00K 10-Q · filed 2014-08-07 | $1.88M derived: sum of 3 quarters · filed 2014-08-07 | -$499.00K derived: sum of 4 quarters · filed 2014-08-07 | $8.21M 10-Q · filed 2013-08-08 | |||
| 2013-03-31 | $1.18M 10-Q · filed 2014-05-08 | $3.60M derived: sum of 2 quarters · filed 2014-05-08 | $1.23M derived: sum of 3 quarters · filed 2014-05-08 | |||||
| 2012-12-31 | $2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $50.00K derived: sum of 2 quarters · filed 2014-03-03 | $3.59M 10-K · filed 2014-03-03 | |||||
| 2012-09-30 | -$2.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $1.16M 10-Q · filed 2013-11-12 | ||||||
| 2012-06-30 | $3.54M 10-Q · filed 2013-08-08 | |||||||
| 2011-12-31 | $1.06M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |